APPLICATION
ANDA090205
TYPE
ANDA
ORIGINAL APPROVAL
2009-11-18
LATEST ACTION
2015-12-23
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
ACETAMINOPHENDiscontinued
ACETAMINOPHEN 650MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2015-12-23Labeling · Supplement 3 · standardAP
2014-12-13Labeling · Supplement 2AP
2009-11-18OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.